Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids

Area of Science:

• Neuroscience
• Pharmacology
• Pain Management

Background:

• Spinal opioid-induced itch is a common side effect of pain management.
• Previous theories linked itch to pain inhibition.

Purpose of the Study:

• To investigate the specific molecular mechanisms underlying spinal opioid-induced itch.
• To differentiate the pathways for opioid-induced itch versus analgesia.

Main Methods:

• Investigated the roles of micro-opioid receptor (MOR) isoforms MOR1D and MOR1.
• Examined the interaction between MOR1D and gastrin-releasing peptide receptor (GRPR).
• Utilized molecular and pharmacological inhibition of downstream effectors like PLCβ3 and IP3R3.

Main Results:

• MOR1D, not MOR1, is essential for morphine-induced scratching (MIS).
• MOR1D heterodimerizes with GRPR in the spinal cord to relay itch signals.
• Morphine triggers GRPR and MOR1D internalization; GRP triggers GRPR internalization independently.
• Inhibiting PLCβ3, IP3R3, or MOR1D-GRPR association specifically blocks MIS, not morphine-induced analgesia (MIA).

Conclusions:

• Opioid-induced itch is an active process, independent of analgesia.
• The MOR1D-GRPR pathway mediates opioid-induced itch via unidirectional cross-activation.
• This pathway offers potential targets for preventing opioid-induced itch without affecting pain relief.